Search

everythinglearnresearchcommunity

for

Search:↓

The convention discussed various skin conditions, treatments, and the importance of continuous learning in dermatology nursing.

Alopecia totalis/universalis is a severe form of hair loss where all body hair is lost.

People with alopecia areata have higher rates of mental health issues, autoimmune diseases, and infections.

Children with HIV often have skin problems that can indicate the severity of their immune system damage.

Some hair loss disorders cause permanent loss due to scarring, and treatments like steroids don't always work well.

Tofacitinib can temporarily improve hair growth in alopecia universalis, but its effectiveness may decrease over time.

Eating the right foods is important for skin health and can help treat some skin conditions.

Tofacitinib is a promising treatment for severe alopecia areata, with many patients experiencing complete or partial hair regrowth.

The trial showed that a new under-the-tongue treatment for severe hair loss was somewhat effective in a small group of people.

The document concludes that early recognition and treatment of primary cicatricial alopecia is crucial to prevent permanent hair loss.

Targeted anticancer therapies can cause severe side effects similar to traditional chemotherapy, but with different types.

Cicatricial alopecia, a permanent hair loss condition, is mainly caused by damage to specific hair follicle stem cells and abnormal immune responses, with gene regulator PPAR-y and lipid metabolism disorders playing significant roles.

Various dermatologic treatments were effective for skin conditions like acne, rosacea, hair loss, and psoriasis from December 1986 to December 1987.

Permanent hair loss from cicatricial alopecia is treated by reducing inflammation and managing symptoms, but regrowth in scarred areas is unlikely.

Some drugs can cause skin reactions, which may improve when the drug is stopped, and rapid diagnosis and stopping the drug is crucial.

Polycystic Ovary Syndrome (PCOS) is a hormonal disorder in women that can cause infertility and other health issues, and it may be improved by treatments that increase insulin sensitivity.

Up to half of people experience itchy scalp, often due to skin conditions like seborrheic dermatitis or psoriasis, and treatments vary based on the specific cause.

JAK inhibitors, like baricitinib, are effective and safe for treating alopecia areata.

Topical minoxidil showed promise for early male pattern baldness.

Dr. Vera H. Price's 1979 work emphasizes the importance of accurate diagnosis and personalized treatment for hair loss.

Hair loss has many causes and treatments, and losing some hair daily is normal; proper diagnosis is key, and minoxidil can help treat it.

Hair disorders are caused by a complex mix of biology, genetics, hormones, and environmental factors, affecting hair growth and leading to conditions like alopecia.

Topical corticosteroids are the main treatment for Erosive Pustular Dermatosis, but recurrence is common after stopping treatment.

Alopecia Areata significantly lowers quality of life and current treatments are inadequate, highlighting a need for better therapies and standardized treatment protocols.

COVID-19 may trigger severe skin flare-ups in people with autoimmune conditions like lupus.

About a quarter of the participants experienced hair loss after COVID-19 vaccination.

Hyaluronic acid fillers for temporal lifting can cause hair loss without scarring.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

Up to 50% of scalp hair can be lost before it appears thin, and treatment is only needed for hair loss caused by diseases or deficiencies.